D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Walt Disney
DIS
|
$637M |
| 2 |
Boeing
BA
|
$416M |
| 3 |
Alibaba
BABA
|
$349M |
| 4 |
Advanced Micro Devices
AMD
|
$336M |
| 5 |
JD.com
JD
|
$307M |
Top Sells
| 1 |
Apple
AAPL
|
$1.2B |
| 2 |
Amazon
AMZN
|
$455M |
| 3 |
Procter & Gamble
PG
|
$375M |
| 4 |
Costco
COST
|
$315M |
| 5 |
JPMorgan Chase
JPM
|
$298M |
Sector Composition
| 1 | Technology | 20.2% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.29% |
| 4 | Financials | 8.38% |
| 5 | Communication Services | 8.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Amgen
AMGN
$153B
| $24.5M | 0.03% |
96,571
-124,129
| -56% | -$31.5M |
|
477
Groupon
GRPN
$971M
| $24.5M | 0.03% |
1,203,087
+1,179,000
| +4,895% | +$24.1M |
|
478
CGI
GIB
$21.6B
| $24.5M | 0.03% |
361,365
-30,100
| -8% | -$2.04M |
|
479
Check Point Software Technologies
CHKP
$20.7B
| $24.5M | 0.03% |
203,296
-460,300
| -69% | -$55.4M |
|
480
CareTrust REIT
CTRE
$7.56B
| $24.4M | 0.03% |
1,373,750
+693,318
| +102% | +$12.3M |
|
481
Nice
NICE
$8.67B
| $24.4M | 0.03% |
107,525
+67,952
| +172% | +$15.4M |
|
482
Texas Capital Bancshares
TCBI
$3.96B
| $24.3M | 0.02% |
779,834
-10,704
| -1% | -$333K |
|
|
MDRX
483
DELISTED
Veradigm Inc. Common Stock
MDRX
| $24.2M | 0.02% |
2,975,995
-235,361
| -7% | -$1.92M |
|
484
Ball Corp
BALL
$13.9B
| $24.2M | 0.02% |
291,211
-342,072
| -54% | -$28.4M |
|
485
NCR Voyix
VYX
$1.84B
| $24M | 0.02% |
1,770,312
-128,442
| -7% | -$1.74M |
|
|
KSU
486
DELISTED
Kansas City Southern
KSU
| $24M | 0.02% |
132,479
+94,347
| +247% | +$17.1M |
|
487
Best Buy
BBY
$16.1B
| $23.9M | 0.02% |
214,773
+186,315
| +655% | +$20.7M |
|
488
Resideo Technologies
REZI
$5.32B
| $23.9M | 0.02% |
2,168,633
-31,646
| -1% | -$348K |
|
489
Douglas Emmett
DEI
$2.83B
| $23.8M | 0.02% |
947,265
+207,019
| +28% | +$5.2M |
|
490
Leidos
LDOS
$23B
| $23.7M | 0.02% |
266,105
+186,805
| +236% | +$16.7M |
|
491
Euronet Worldwide
EEFT
$3.74B
| $23.7M | 0.02% |
260,038
+28,264
| +12% | +$2.57M |
|
492
Axalta
AXTA
$6.89B
| $23.5M | 0.02% |
1,061,332
+430,422
| +68% | +$9.54M |
|
493
Healthpeak Properties
DOC
$12.8B
| $23.4M | 0.02% |
862,515
-292,098
| -25% | -$7.93M |
|
|
MIK
494
DELISTED
Michaels Stores, Inc
MIK
| $23.2M | 0.02% |
2,404,370
+1,464,532
| +156% | +$14.1M |
|
495
Boston Scientific
BSX
$159B
| $23.1M | 0.02% |
605,574
-2,543,728
| -81% | -$97.2M |
|
496
Plains GP Holdings
PAGP
$3.64B
| $23.1M | 0.02% |
3,790,981
-549,853
| -13% | -$3.35M |
|
497
Progressive
PGR
$143B
| $23M | 0.02% |
243,182
+54,105
| +29% | +$5.12M |
|
498
JetBlue
JBLU
$1.85B
| $22.9M | 0.02% |
2,020,466
+1,503,603
| +291% | +$17M |
|
499
MGM Resorts International
MGM
$9.98B
| $22.8M | 0.02% |
1,050,110
-789,127
| -43% | -$17.2M |
|
500
Thermo Fisher Scientific
TMO
$186B
| $22.8M | 0.02% |
51,574
+5,640
| +12% | +$2.49M |
|